Powder Gains Ground
Powder-format carb blocker supplements are absorbing share that capsules and gels have held for years. Contrive Datum Insights projects the powder line to expand at 11.4% annually through 2034, pushing its portion of global revenue from 16% in 2025 to 20% by 2034 and its value from USD 0.2144 billion to USD 0.568 billion. Capsules and gels remain the format most buyers reach for today, but the growth is now happening elsewhere in the category.
The finding comes from "Carb Blocker Supplements Market Size, Share & Industry Analysis, By Type (Capsules/Gels, Tablets, Powder, Liquid, Other), Application (Hypermarkets/Supermarkets, Convenience Stores, Specialty Coffee Shops, Online Retail, Others), Ingredient source (White Kidney Bean Extract, Chitosan, Multi-Ingredient Blends, Other Botanical Extracts), End user (Weight Management Consumers, Diabetic and Pre-Diabetic Consumers, Sports Nutrition and Fitness Consumers), Price tier (Mass Market/Mainstream, Premium/Specialty), and Regional Forecast, 2026-2034". The report sizes the global market at USD 1.34 billion in 2025, rising to USD 1.46 billion in 2026 and to USD 2.84 billion by 2034; a compound annual growth rate of 8.68% for the period as a whole.
Rising rates of obesity and overweight prevalence worldwide drive that expansion, an impact the study rates high. Powder's pull comes partly from how it is used: it mixes into a shake or a glass of water before a meal, a format that fits routines already built around fitness and diabetic-management products, two buyer groups the report tracks separately from the general weight-management audience. That positioning helps explain why powder is compounding faster than the 8.68% market average while capsules and gels, still the largest format at 42% of 2025 revenue and USD 0.5628 billion, grow at 8.07%: close to, but under, the category as a whole.
Where the Growth Sits Regionally
North America accounts for 38% of 2025 revenue (USD 0.5092 billion), the largest of any region, and the study puts its 2034 total at USD 0.9656 billion. The United States alone is the single largest country market, at USD 0.4328 billion in 2025 (32.3% of the global total). Asia Pacific is the region gaining ground: its share climbs from 26% in 2025 to 32% in 2034, with revenue rising from USD 0.3484 billion to USD 0.9088 billion, a faster climb than North America's over the same years. Middle East and Africa stays the smallest region across the period, holding at 5% of revenue in both 2025 and 2034.
Set against powder's 11.4%, capsules and gels' 8.07% growth still keeps the format ahead in absolute revenue through the decade; the study puts its share at 40% of the market by 2034, down only two points from 42% today. Scale, not speed, is what keeps capsules and gels in front: a two-point share loss over nine years is a slow retreat, not a collapse, and it is the segment new entrants still have to contend with even as powder draws the faster growth.
The report models bear and bull cases alongside the base forecast, putting 2034 revenue at USD 2.56 billion and USD 3.12 billion respectively against the USD 2.84 billion base figure. It segments the market across five axes with revenue and growth rates for every line from 2020 to 2034, covers all five regions with country-level detail, and includes the competitive landscape and research methodology. Delivered as a PDF; a free sample is available on request.